DevaCell has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 50% patents are active. The USA & Europe (EPO) is where DevaCell has filed the maximum number of patents. Parallelly, the United States seems to be the main focused
I2 Pharmaceuticals has a total of 73 patents globally, out of which 31 have been granted. Of these 73 patents, more than 20% patents are active. The United States of America is where I2 Pharmaceuticals has filed the maximum number of patents, followed by Germany and Europe. Parallelly, United States
Arixa Pharmaceuticals has a total of 75 patents globally, out of which 26 have been granted. Of these 75 patents, more than 84% patents are active. The United States of America is where Arixa Pharmaceuticals has filed the maximum number of patents, followed by Canada and Australia. Parallelly, United States
Surface Ophthalmics has a total of 28 patents globally, out of which 2 have been granted. Of these 28 patents, more than 64% patents are active. The United States of America is where Surface Ophthalmics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America
Machavert Pharmaceuticals has a total of 20 patents globally, out of which 2 have been granted. Of these 20 patents, more than 30% patents are active. The United States of America is where Machavert Pharmaceuticals has filed the maximum number of patents. Parallelly, United States of America seems to be
Obsidian Therapeutics has a total of 127 patents globally, out of which 7 have been granted. Of these 127 patents, more than 81% patents are active. The USA is where Obsidian Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Hong Kong. Parallelly, the US seems
TearClear has a total of 65 patents globally, out of which 6 have been granted. Of these 65 patents, more than 84% patents are active. The United States of America is where TearClear has filed the maximum number of patents. Parallelly, United States of America seems to be the main
Eternatear has a total of 15 patents globally, out of which 3 have been granted. Of these 15 patents, more than 86% patents are active. The United States of America is where Eternatear has filed the maximum number of patents. Parallelly, United States of America seems to be the main
Recursion Pharmaceuticals has a total of 149 patents globally, out of which 58 have been granted. Of these 149 patents, more than 78% patents are active. United States of America is where Recursion Pharmaceuticals has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of
EIP Pharma has a total of 47 patents globally, out of which 24 have been granted. Of these 47 patents, more than 65% patents are active. The USA is where EIP Pharma has filed the maximum number of patents, followed by Japan and China. Parallelly, the USA seems to be
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.